| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.35 | 0.3 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |